120 related articles for article (PubMed ID: 38886094)
21. Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study.
Huijben JA; Kramer A; Kerschbaum J; de Meester J; Collart F; Arévalo OLR; Helve J; Lassalle M; Palsson R; Ten Dam M; Casula A; Methven S; Ortiz A; Ferraro PM; Segelmark M; Mingo PU; Arici M; Reisæter AV; Stendahl M; Stel VS; Jager KJ
Nephrol Dial Transplant; 2023 Mar; 38(4):1027-1040. PubMed ID: 35974693
[TBL] [Abstract][Full Text] [Related]
22. Incidence and Outcomes of Patients Receiving Chronic Kidney Replacement Therapy Admitted to Scottish ICUs Between 2009 and 2019-A National Observational Cohort Study.
Lambourg E; Walker H; Campbell J; Watters C; O'Neil M; Donaldson L; Siddiqui MK; Almond A; Buck K; Cousland Z; Joss N; Metcalfe W; Methven S; Sanu V; Spalding E; Traynor JP; Lone NI; Bell S;
Crit Care Med; 2023 Jan; 51(1):69-79. PubMed ID: 36377890
[TBL] [Abstract][Full Text] [Related]
23. Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19.
Wijkström J; Caldinelli A; Bruchfeld A; Nowak A; Artborg A; Stendahl M; Segelmark M; Lindholm B; Bellocco R; Rydell H; Evans M
Nephrol Dial Transplant; 2023 Oct; 38(11):2607-2616. PubMed ID: 37433606
[TBL] [Abstract][Full Text] [Related]
24. Sex Differences in Kidney Replacement Therapy Initiation and Maintenance.
Antlanger M; Noordzij M; van de Luijtgaarden M; Carrero JJ; Palsson R; Finne P; Hemmelder MH; Aresté-Fosalba N; Reisæter AV; Cases A; Traynor JP; Kramar R; Massy Z; Jager KJ; Hecking M;
Clin J Am Soc Nephrol; 2019 Nov; 14(11):1616-1625. PubMed ID: 31649071
[TBL] [Abstract][Full Text] [Related]
25. Sex differences in the likelihood of pre-emptive living donor kidney transplantation, and outcomes after kidney transplantation in children and adolescents.
Lalji R; Francis A; Blazek K; Teixeira-Pinto A; Wong G; Johnson DW
Pediatr Transplant; 2022 Aug; 26(5):e14224. PubMed ID: 35014131
[TBL] [Abstract][Full Text] [Related]
26. Understanding International Variations in Kidney Failure Incidence and Initiation of Replacement Therapy.
Alencar de Pinho N; Henn L; Raina R; Reichel H; Lopes AA; Combe C; Speyer E; Bieber B; Robinson BM; Stengel B; Pecoits-Filho R;
Kidney Int Rep; 2022 Nov; 7(11):2364-2375. PubMed ID: 36531894
[TBL] [Abstract][Full Text] [Related]
27. Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Mehta R; Cai X; Lee J; Xie D; Wang X; Scialla J; Anderson AH; Taliercio J; Dobre M; Chen J; Fischer M; Leonard M; Lash J; Hsu CY; de Boer IH; Feldman HI; Wolf M; Isakova T;
Am J Kidney Dis; 2020 Jun; 75(6):908-918. PubMed ID: 31864822
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
[TBL] [Abstract][Full Text] [Related]
29. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
Trials; 2020 May; 21(1):428. PubMed ID: 32450917
[TBL] [Abstract][Full Text] [Related]
30. Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort study.
Wu H; Lau ESH; Yang A; Szeto CC; Ma RCW; Kong APS; Chow E; So WY; Chan JCN; Luk AOY
Lancet Reg Health West Pac; 2021 Jun; 11():100165. PubMed ID: 34327367
[TBL] [Abstract][Full Text] [Related]
31. The Latin American Dialysis and Renal Transplantation Registry: report 2019.
Luxardo R; Ceretta L; González-Bedat M; Ferreiro A; Rosa-Diez G
Clin Kidney J; 2022 Mar; 15(3):425-431. PubMed ID: 35211302
[TBL] [Abstract][Full Text] [Related]
32. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.
Disney AP
Am J Kidney Dis; 1995 Jan; 25(1):165-75. PubMed ID: 7810521
[TBL] [Abstract][Full Text] [Related]
33. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
[TBL] [Abstract][Full Text] [Related]
34. Association of Primary Kidney Disease Type and Donor Relatedness With Live Donor Kidney Transplant Outcomes: An Analysis of ANZDATA.
Yu D; Malacova E; Hurst C; Ng MSY; Mallett AJ
Am J Kidney Dis; 2023 Nov; 82(5):569-580.e1. PubMed ID: 37385397
[TBL] [Abstract][Full Text] [Related]
35. Evaluating data quality in the Australian and New Zealand dialysis and transplant registry using administrative hospital admission datasets and data-linkage.
Palamuthusingam D; Pascoe EM; Hawley CM; Johnson DW; Ratnayake G; McDonald S; Boudville N; Jose M; Fahim M
Health Inf Manag; 2023 Sep; 52(3):212-220. PubMed ID: 35695032
[No Abstract] [Full Text] [Related]
36. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.
Tang W; Mohandas J; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
BMC Nephrol; 2012 Dec; 13():164. PubMed ID: 23206870
[TBL] [Abstract][Full Text] [Related]
37. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis.
Huria T; Palmer S; Beckert L; Williman J; Pitama S
Int J Equity Health; 2018 Feb; 17(1):27. PubMed ID: 29458366
[TBL] [Abstract][Full Text] [Related]
38. Morbidity burden of end-stage kidney disease in Australia: hospital separation rates among people receiving kidney replacement therapy.
McDonald SP; Tong B
Nephrology (Carlton); 2011 Nov; 16(8):758-66. PubMed ID: 21707839
[TBL] [Abstract][Full Text] [Related]
39. ABO blood group relationships to kidney transplant recipient and graft outcomes.
Ng MSY; Ullah S; Wilson G; McDonald S; Sypek M; Mallett AJ
PLoS One; 2020; 15(7):e0236396. PubMed ID: 32702043
[TBL] [Abstract][Full Text] [Related]
40. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.
Thurlow JS; Joshi M; Yan G; Norris KC; Agodoa LY; Yuan CM; Nee R
Am J Nephrol; 2021; 52(2):98-107. PubMed ID: 33752206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
